Insights Into Timing, Risk Factors, and Outcomes of Stroke and Transient Ischemic Attack After Transcatheter Aortic Valve Replacement in the PARTNER Trial (Placement of Aortic Transcatheter Valves) - PubMed (original) (raw)

Randomized Controlled Trial

doi: 10.1161/CIRCINTERVENTIONS.115.002981.

Shikhar Agarwal 2, D Craig Miller 2, John G Webb 2, Michael Mack 2, Stephen Ellis 2, Howard C Herrmann 2, Augusto D Pichard 2, E Murat Tuzcu 2, Lars G Svensson 2, Craig R Smith 2, Jeevanantham Rajeswaran 2, John Ehrlinger 2, Susheel Kodali 2, Raj Makkar 2, Vinod H Thourani 2, Eugene H Blackstone 2, Martin B Leon 2

Affiliations

Randomized Controlled Trial

Insights Into Timing, Risk Factors, and Outcomes of Stroke and Transient Ischemic Attack After Transcatheter Aortic Valve Replacement in the PARTNER Trial (Placement of Aortic Transcatheter Valves)

Samir Kapadia et al. Circ Cardiovasc Interv. 2016 Sep.

Abstract

Background: Prior studies of stroke and transient ischemic attack (TIA) after transcatheter aortic valve replacement (TAVR) are limited by reporting and follow-up variability. This is a comprehensive analysis of time-related incidence, risk factors, and outcomes of these events.

Methods and results: From April 2007 to February 2012, 2621 patients, aged 84±7.2 years, underwent transfemoral (TF; 1521) or transapical (TA; 1100) TAVR in the PARTNER trial (Placement of Aortic Transcatheter Valves; as-treated), including the continued access registry. Stroke and TIA were identified by protocol and adjudicated by a Clinical Events Committee. Within 30 days of TAVR, 87 (3.3%) patients experienced a stroke (TF 58 [3.8%]; TA 29 [2.7%]; P=0.09), 85% within 1 week. Instantaneous stroke risk peaked on day 2, then fell to a low prolonged risk of 0.8% by 1 to 2 weeks. Within 30 days, 13 (0.50%) patients experienced a TIA (TF 10 [0.67%]; TA 3 [0.27%]; P>0.17). Stroke and TIA were associated with lower 1-year survival than expected (TF 47% after stroke versus 82%, and 64% after TIA versus 83%; TA 53% after stroke versus 80%, and 64% after TIA versus 83%). Risk factors for early stroke after TA-TAVR included more postdilatations, pure aortic stenosis without regurgitation, and possibly more pacing runs, earlier date of procedure, and no dual antiplatelet therapy; high pre-TAVR aortic peak gradient was a risk factor for stroke early after TF-TAVR.

Conclusions: Risk of stroke or TIA is highest early after TAVR and is associated with increased 1-year mortality. Modifications of TAVR, emboli-prevention devices, and better intraprocedural pharmacological protection may mitigate this risk.

Clinical trial registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00530894.

Keywords: stroke; transapical; transcatheter aortic valve replacement; transfemoral; transient ischemic attack.

© 2016 American Heart Association, Inc.

PubMed Disclaimer

Comment in

Publication types

MeSH terms

LinkOut - more resources